Security key
35104E100
4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT)
CUSIP: 35104E100
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 51,571,939
- Total 13F shares
- 40,369,426
- Share change
- -2,724,903
- Total reported value
- $149,859,289
- Put/Call ratio
- 199%
- Price per share
- $3.71
- Number of holders
- 117
- Value change
- -$9,235,482
- Number of buys
- 58
- Number of sells
- 60
Report period
Q2 2025
Institutions
117
Top holders
10
FDMT full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
4D Molecular Therapeutics, Inc. SEC filings
4D Molecular Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 35104E100
Recent filing periods:
Top shareholders of FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
— |
1.5%
|
677,600
|
$2,202,200 | -$7,393,006 | 31 Mar 2025 | |
| Deep Track Capital, LP |
13D/G
|
— |
1.3%
|
609,900
|
$1,982,175 | $0 | 31 Dec 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
3/4/5
13F
|
10%+ Owner · Company |
8.8%
from 13F
|
8,173,211
mixed-class rows
|
$74,517,236 | — | 09 Dec 2024 | |
| BVF INC/IL |
13F
|
Company |
8.8%
|
4,561,289
|
$14,732,963 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
8.8%
|
4,547,152
|
$14,687,300 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
8.1%
|
4,168,394
|
$13,463,913 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.3%
|
2,757,490
|
$8,906,693 | — | 31 Mar 2025 | |
| Novo Holdings A/S |
13F
|
Company |
3.8%
|
1,950,000
|
$6,298,500 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.7%
|
1,891,935
|
$6,867,691 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
3.4%
|
1,776,743
|
$5,738,880 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
3.2%
|
1,633,987
|
$5,277,778 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
2.4%
|
1,250,181
|
$4,038,085 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
2%
|
1,027,950
|
$3,320,279 | — | 31 Mar 2025 | |
| Redmile Group, LLC |
13F
|
Company |
1.9%
|
997,235
|
$3,221,069 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
963,269
|
$3,112,108 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.7%
|
886,705
|
$2,864,059 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.4%
|
698,308
|
$2,255,535 | — | 31 Mar 2025 | |
| Venrock Adviser, LLC |
13F
|
Company |
1.3%
|
677,600
|
$2,188,648 | — | 31 Mar 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
1.3%
|
650,956
|
$2,102,588 | — | 31 Mar 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
1%
|
527,270
|
$1,703,082 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.95%
|
490,400
|
$1,583,992 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.89%
|
461,457
|
$1,490,506 | — | 31 Mar 2025 | |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND |
13F
|
Company |
0.8%
|
412,000
|
$1,330,760 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.78%
|
400,606
|
$1,290,000 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.74%
|
380,920
|
$1,230,372 | — | 31 Mar 2025 | |
| Decheng Capital LLC |
13F
|
Company |
0.65%
|
335,515
|
$1,083,713 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.64%
|
331,211
|
$1,069,812 | — | 31 Mar 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.58%
|
300,000
|
$969,000 | — | 31 Mar 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.57%
|
294,379
|
$950,844 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.55%
|
282,781
|
$913,383 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.48%
|
247,471
|
$799,331 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.46%
|
236,445
|
$763,717 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.46%
|
236,157
|
$762,787 | — | 31 Mar 2025 | |
| Peapod Lane Capital LLC |
13F
|
Company |
0.38%
|
195,853
|
$632,605 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.31%
|
158,288
|
$511,270 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.29%
|
150,314
|
$485,515 | — | 31 Mar 2025 | |
| Perigon Wealth Management, LLC |
13F
|
Company |
0.28%
|
146,133
|
$472,010 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.27%
|
140,879
|
$455,040 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.26%
|
134,849
|
$435,561 | — | 31 Mar 2025 | |
| Privium Fund Management B.V. |
13F
|
Company |
0.25%
|
131,000
|
$423,130 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.23%
|
117,768
|
$380,391 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.19%
|
97,042
|
$313,445 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.16%
|
85,080
|
$274,809 | — | 31 Mar 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
84,175
|
$271,885 | — | 31 Mar 2025 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.16%
|
84,172
|
$271,875 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.14%
|
74,566
|
$241,498 | — | 31 Mar 2025 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.14%
|
73,422
|
$237,153 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.14%
|
70,803
|
$228,681 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.14%
|
70,720
|
$228,426 | — | 31 Mar 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.11%
|
55,870
|
$180,460 | — | 31 Mar 2025 |
Institutional Holders of 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT) as of Q2 2025
As of 30 Jun 2025,
4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT) was held by
117 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
40,369,426 shares.
The largest 10 holders included
BVF INC/IL, RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, BlackRock, Inc., VANGUARD GROUP INC, NOVO HOLDINGS A/S, JANUS HENDERSON GROUP PLC, FEDERATED HERMES, INC., MILLENNIUM MANAGEMENT LLC, and STATE STREET CORP.
This page lists
118
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
122
Q2 2025 holders
117
Holder diff
-5
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.